CARL STEIN: Open Payments
NPI 1053346957 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 15 payments from 7 companies in 2025. Trend: 2023 $5,846 · 2024 $1,348 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 8 | $260 |
| Organon LLC | 1 | $168 |
| Madrigal Pharmaceuticals | 1 | $130 |
| INTUITIVE SURGICAL, INC. | 1 | $130 |
| Lilly USA, LLC | 1 | $123 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $118 |
| Merck Sharp & Dohme LLC | 2 | $61 |
Products named: APRETUDE, VTAMA, REZDIFFRA, Da Vinci Surgical System, ZEPBOUND, JOURNAVX, DOVATO.
Industry payments across CA — which companies pay providers there.
